ATE267608T1 - Verwendung von fsh zur behandlung von infertilität - Google Patents
Verwendung von fsh zur behandlung von infertilitätInfo
- Publication number
- ATE267608T1 ATE267608T1 AT01900491T AT01900491T ATE267608T1 AT E267608 T1 ATE267608 T1 AT E267608T1 AT 01900491 T AT01900491 T AT 01900491T AT 01900491 T AT01900491 T AT 01900491T AT E267608 T1 ATE267608 T1 AT E267608T1
- Authority
- AT
- Austria
- Prior art keywords
- fsh
- treat infertility
- infertility
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00300591 | 2000-01-27 | ||
| EP00302840A EP1142582A1 (de) | 2000-04-04 | 2000-04-04 | Verwendung von FSH zur Behandlung von Infertilität |
| PCT/GB2001/000065 WO2001054715A1 (en) | 2000-01-27 | 2001-01-09 | Use of fsh for treating infertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267608T1 true ATE267608T1 (de) | 2004-06-15 |
Family
ID=26072975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01900491T ATE267608T1 (de) | 2000-01-27 | 2001-01-09 | Verwendung von fsh zur behandlung von infertilität |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7291593B2 (de) |
| EP (2) | EP1442748A1 (de) |
| JP (1) | JP5170928B2 (de) |
| KR (2) | KR100871499B1 (de) |
| CN (1) | CN1418107A (de) |
| AR (1) | AR027287A1 (de) |
| AT (1) | ATE267608T1 (de) |
| AU (1) | AU783121B2 (de) |
| BG (1) | BG65915B1 (de) |
| BR (1) | BR0107881A (de) |
| CA (1) | CA2397680A1 (de) |
| CZ (1) | CZ302835B6 (de) |
| DE (1) | DE60103503T3 (de) |
| DK (1) | DK1250148T4 (de) |
| EA (1) | EA004924B1 (de) |
| EE (1) | EE05444B1 (de) |
| ES (1) | ES2217113T5 (de) |
| HR (1) | HRP20020630A2 (de) |
| HU (1) | HU230833B1 (de) |
| IL (2) | IL150837A0 (de) |
| MX (1) | MXPA02007233A (de) |
| NO (1) | NO324626B1 (de) |
| PL (1) | PL211113B1 (de) |
| PT (1) | PT1250148E (de) |
| RS (1) | RS50805B (de) |
| SI (1) | SI1250148T2 (de) |
| SK (1) | SK287717B6 (de) |
| TR (1) | TR200401810T4 (de) |
| WO (1) | WO2001054715A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003022302A2 (en) * | 2001-09-12 | 2003-03-20 | Applied Research Systems Ars Holding N.V. | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
| AU2002324183B2 (en) * | 2001-09-12 | 2007-10-25 | Merck Serono Sa | Use of hCG and LH in controlled ovarian hyperstimulation |
| PL369021A1 (en) * | 2001-09-12 | 2005-04-18 | Applied Research Systems Ars Holding N.V. | Use of hcg and lh in controlled ovarian hyperstimulation |
| UA88879C2 (en) * | 2003-09-02 | 2009-12-10 | Эплайд Рисерч Системз Эрс Холдинг Н.В. | Fsh glycosylation mutant |
| US7481748B2 (en) * | 2005-09-22 | 2009-01-27 | Kurt Manufacturing Company, Inc. | Locking mechanism for a bicycle trainer |
| WO2008140794A1 (en) * | 2007-05-11 | 2008-11-20 | The Texas A & M University System | Hormone normalization therapy and uses thereof |
| AR081755A1 (es) | 2010-04-02 | 2012-10-17 | Hanmi Holdings Co Ltd | Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo |
| CA2934579A1 (en) * | 2013-12-20 | 2015-06-25 | Fertilify Inc. | Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health |
| AU2018326556A1 (en) * | 2017-09-01 | 2020-03-05 | Ferring B.V. | Composition for controlled ovarian stimulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725579A (en) * | 1985-02-21 | 1988-02-16 | Serono Laboratories, Inc. | Method of in vitro fertilization by a unique combination of gonadotropins |
-
2001
- 2001-01-09 CA CA002397680A patent/CA2397680A1/en not_active Abandoned
- 2001-01-09 CN CN01806573A patent/CN1418107A/zh active Pending
- 2001-01-09 AT AT01900491T patent/ATE267608T1/de active
- 2001-01-09 EP EP04006375A patent/EP1442748A1/de not_active Withdrawn
- 2001-01-09 ES ES01900491T patent/ES2217113T5/es not_active Expired - Lifetime
- 2001-01-09 PT PT01900491T patent/PT1250148E/pt unknown
- 2001-01-09 DK DK01900491T patent/DK1250148T4/da active
- 2001-01-09 TR TR2004/01810T patent/TR200401810T4/xx unknown
- 2001-01-09 EA EA200200801A patent/EA004924B1/ru not_active IP Right Cessation
- 2001-01-09 IL IL15083701A patent/IL150837A0/xx unknown
- 2001-01-09 SI SI200130111T patent/SI1250148T2/sl unknown
- 2001-01-09 US US10/182,138 patent/US7291593B2/en not_active Expired - Lifetime
- 2001-01-09 WO PCT/GB2001/000065 patent/WO2001054715A1/en active IP Right Grant
- 2001-01-09 KR KR1020077017998A patent/KR100871499B1/ko active IP Right Grant
- 2001-01-09 MX MXPA02007233A patent/MXPA02007233A/es active IP Right Grant
- 2001-01-09 EE EEP200200415A patent/EE05444B1/xx unknown
- 2001-01-09 EP EP01900491A patent/EP1250148B2/de not_active Expired - Lifetime
- 2001-01-09 RS YUP-567/02A patent/RS50805B/sr unknown
- 2001-01-09 CZ CZ20022555A patent/CZ302835B6/cs not_active IP Right Cessation
- 2001-01-09 DE DE60103503T patent/DE60103503T3/de not_active Expired - Lifetime
- 2001-01-09 HU HU0204324A patent/HU230833B1/hu unknown
- 2001-01-09 AU AU25321/01A patent/AU783121B2/en not_active Expired
- 2001-01-09 KR KR1020027009518A patent/KR100871502B1/ko active IP Right Grant
- 2001-01-09 SK SK1096-2002A patent/SK287717B6/sk not_active IP Right Cessation
- 2001-01-09 BR BR0107881-0A patent/BR0107881A/pt not_active Application Discontinuation
- 2001-01-09 PL PL356925A patent/PL211113B1/pl unknown
- 2001-01-09 JP JP2001554698A patent/JP5170928B2/ja not_active Expired - Lifetime
- 2001-01-25 AR ARP010100325A patent/AR027287A1/es unknown
-
2002
- 2002-07-11 NO NO20023354A patent/NO324626B1/no not_active IP Right Cessation
- 2002-07-22 IL IL150837A patent/IL150837A/en active IP Right Grant
- 2002-07-23 BG BG106943A patent/BG65915B1/bg unknown
- 2002-07-25 HR HRP20020630 patent/HRP20020630A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE419856T1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| ATE401909T1 (de) | Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis | |
| ATE308364T1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE60105295D1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
| ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| ATE338552T1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| ATE254913T1 (de) | Diacerein zur behandlung von psoriasis | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE339955T1 (de) | Verwendung von escitalopram zur behandlung von generalisierten angstzuständen | |
| ATE267608T1 (de) | Verwendung von fsh zur behandlung von infertilität | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60104791D1 (de) | Cyclobutendion-Derivate zur Behandlung von Artherosclerose | |
| DE60103685D1 (de) | Behandlung von Poriomania | |
| ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| ATE270545T1 (de) | Verwendung von nmda antagonisten zur behandlung des reizkolons | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| DE60130524D1 (de) | Verfahren zur elektrochemischen Behandlung von Artikeln | |
| DE60005685D1 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
| ATE255892T1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1250148 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1250148 Country of ref document: EP |